六味地黄汤加减配合二甲双胍及阿托伐他汀治疗2型糖尿病合并高脂血症的临床研究

【目的】观察六味地黄汤加减配合二甲双胍及阿托伐他汀治疗2型糖尿病合并高脂血症的治疗效果。【方法】将120例2型糖尿病合并高脂血症患者随机分为治疗组和对照组各60例,对照组给予二甲双胍及阿托伐他汀治疗,治疗组给予六味地黄汤加减配合二甲双胍及阿托伐他汀治疗,2组均以12周为1个疗程。比较2组患者治疗前后空腹血糖(FBG)、餐后2h血糖(2hPG)、糖化血红蛋白(HbA1C)、总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)水平的变化情况,并评价2组临床疗效。【结果】(1)治疗组总有效率为95.0%,对照组为83.3%,治疗组疗效优于对照组,差异有统计学意义(P0.05)。(2)治疗后,2组患者的FBG、2hPG与HbA1C表达水平均较治疗前显著降低(P0.001),且治疗组治疗后患者的FBG、2hPG、HbA1C表达水平均显著低于对照组(P0.05或P0.01或P0.001)。(3)治疗后,2组患者的TC、TG与LDL-C表达水平均较治疗前显著降低(P0.001),HDL-C表达水平均较治疗前显著升高(P0.001),且治疗组患者的TC、TG表达水平显著低于对照组(P0.05或P0.001),HDL-C表达水平显著高于对照组(P0.001)。【结论】六味地黄汤加减配合二甲双胍及阿托伐他汀治疗2型糖尿病合并高脂血症疗效显著,其疗效优于单纯二甲双胍及阿托伐他汀治疗。

Clinical Study of Modified Liuwei Dihuang Decoction Combined with Metformin Plus Atorvastatin for Treatment of Type 2 Diabetes Mellitus Complicated with Hyperlipidemia

Objective To study the clinical efficacy of modified Liuwei Dihuang Decoction (LDD) combined with metformin plus atorvastatin for the treatment of type 2 diabetes mellitus (T2DM) complicated with hyperlipidemia. Methods A total of 120 cases of T2DM patients complicated with hyperlipidemia were randomly divided into study group (N=60) and control group (N=60), which were treated with LDD combined with metformin plus atorvastatin orally, and with oral use of metformin plus atorvastatin respectively. The course of treatment lasted for 12 weeks. Before and after treatment, we compared the blood levels of fasting blood glucose (FBG), 2-hour postprandial blood glucose(2hPG), glycosylated hemoglobin(HbA1C), total cholesterol(TC), triglyceride(TG), high-density lipoprotein cholesterol(HDL-C), and low-density lipoprotein cholesterol(LDL-C) in the two groups. After treatment, we evaluated the therapeutic effect of the two groups. Results (1) The total effective rate of the study group was 95.0％, and that of the control group was 83.3％, the effective rate of the study group being significantly higher than that of the control group (P < 0.05). (2) After treatment, the blood levels of FBG, 2hPG and HbA1C of both groups were significantly lower than pre-treatment levels (P <0.001), and the levels of FBG, 2hPG and HbA1C of the study group were significantly lower than those of the control group (P<0.05, P<0.01 or P<0.001). (3) After treatment, the TC, TG and LDL-C levels of both groups were significantly lower and HDL-C was higher than pre-treatment levels (P < 0.001); the levels of TC and TG levels of the study group were significantly lower and HDL-C was higher than those of the control group (P < 0.05 or P < 0.001). Conclusion LDD combined with metformin plus atorvastatin exerts certain effect for the treatment of T2DM complicated with hyperlipidemia, and is more effective than metformin or atorvastatin alone.